Milind Deshpande
2013
In 2013, Milind Deshpande earned a total compensation of $4.3M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 183% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,893 |
|---|---|
| Option Awards | $3,679,998 |
| Salary | $435,583 |
| Other | $7,992 |
| Total | $4,272,466 |
Deshpande received $3.7M in option awards, accounting for 86% of the total pay in 2013.
Deshpande also received $148.9K in non-equity incentive plan, $435.6K in salary and $8K in other compensation.
Rankings
In 2013, Milind Deshpande's compensation ranked 1,583rd out of 12,286 executives tracked by ExecPay. In other words, Deshpande earned more than 87.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,583 out of 12,286 | 87th |
Division Manufacturing | 520 out of 4,612 | 89th |
Major group Chemicals And Allied Products | 138 out of 1,462 | 91st |
Industry group Drugs | 95 out of 1,156 | 92nd |
Industry Pharmaceutical Preparations | 83 out of 890 | 91st |
Source: SEC filing on April 15, 2016.
Deshpande's colleagues
We found five more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2013.
2013
David Apelian
Achillion Pharmaceuticals
Chief Medical Officer
2013
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2013
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2013
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
2013
Michael Kishbauch
Achillion Pharmaceuticals